Mindblown: a blog about philosophy.
-
NVIDIA CEO Jensen Huang Says the AI Selloff Is a Buying Opportunity
NVIDIA CEO Jensen Huang says the AI selloff is temporary. Here’s why he believes the AI infrastructure boom is only just beginning.
-
General Mills Stock: Cheap Value or Value Trap?
General Mills (NYSE: GIS) isn’t a stock you trade. It’s a stock you own. That distinction matters more than ever after the company’s fiscal 2026 fourth-quarter report, released July 1. Shares sit near their 2026 lows around $36, well below the stock’s 200-day moving average of roughly $42. However, the dividend yields close to 6.7%…
-
Despite Disney’s Downturn, Here’s Why Contrarianism Requires Caution
Although it’s tempting to believe that mean reversion is a standard operating protocol, that might not necessarily apply to Disney stock.
-
Why the Lithium Market Could Be Entering a Blockbuster Bull Cycle
Lithium demand is rising as EVs and renewable energy expand. Explore lithium stocks and ETFs positioned for the next battery market cycle.
-
The Semiconductor Boom Just Entered Its Second Act
Nvidia led the AI revolution, but the next wave may belong to semiconductor companies powering chips, memory, and AI infrastructure.
-
Top Ways to Trade a Potential Blue Origin IPO
Blue Origin IPO speculation is heating up. Explore ETFs and funds offering exposure to space, AI, and future technology growth.
-
3 Energy ETFs to Buy as U.S.-Iran Tensions Send Oil Prices Higher
Oil prices are climbing as U.S.-Iran tensions return. Discover three energy ETFs that could benefit from renewed strength in the oil market.
-
Rivian Stock Offering Adds to the EV Cautionary Tale
Rivian Automotive (NASDAQ: RIVN) shares plunged 18% Tuesday after the EV maker launched an underwritten public offering of 75 million shares of Class A common stock. Underwriters also received a 30-day option for an additional 11.25 million shares. Based on Monday’s closing price of $20.14, the base offering could raise roughly $1.51 billion — though…
-
With Exxon Mobil (XOM) Stock Down Big Recently, Is Now the Time to Buy?
Amid a major question mark being largely mitigated, Exxon Mobil stock presents an intriguing case for speculators.
-
Biotech Is Booming Again: Here’s Why Investors Are Paying Attention
Biotech is gaining momentum as acquisitions, AI, and medical breakthroughs fuel growth. Here are three biotech ETFs to watch.
Got any book recommendations?